{{Rsnum
|rsid=263
|Gene=LPL
|Chromosome=8
|position=19955301
|Orientation=plus
|GMAF=0.2374
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=LPL
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.9 | 26.5 | 3.5
| HCB | 60.6 | 35.0 | 4.4
| JPT | 61.9 | 32.7 | 5.3
| YRI | 37.4 | 45.6 | 17.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 60.6 | 35.0 | 4.4
| CHD | 57.8 | 33.9 | 8.3
| GIH | 66.3 | 31.7 | 2.0
| LWK | 38.2 | 47.3 | 14.5
| MEX | 69.0 | 24.1 | 6.9
| MKK | 52.6 | 41.0 | 6.4
| TSI | 52.9 | 42.2 | 4.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19888660
|Title=Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China
|OA=1
}}

{{PMID Auto
|PMID=18296645
|Title=Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.
|OA=1
}}

{{PMID Auto
|PMID=19148283
|Title=Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study.
|OA=1
}}

{{PMID Auto
|PMID=20018072
|Title=Different models and single-nucleotide polymorphisms signal the simulated weak gene-gene interaction for a quantitative trait using haplotype-based and mixed models testing.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}